http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20084282-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2008-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44f4b44387216451e026043cca99a85d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5ce6df56a65defb02bf2e0f978b1d53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9226336ac09dfb3026c5852bc04f4ceb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c975c2dc809128b0542b776277fabda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82f63640b74c06dbc9433f8a4237e37f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f37135afe304381c4d45a46fa8c09c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b76ee79a8194e478cef19d41c596182
publicationDate 2008-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20084282-L
titleOfInvention New crystalline form of (5S) -5- [4- (5-chloropyridin-2-yloxy) piperidine-1-sulfonylmethyl] -5-methylimidazoline-2,4-dione (1) and intermediates thereof
abstract New crystal modifications of (5S) -5- [4- (5-chloro-pyridin-2-yloxy) -piperidin-1-sulfonylmethyl] -5-methyl-imidazolidin-2,4-dione are disclosed together with processes for the preparation of such modifications. , pharmaceutical compositions comprising such a modification, and the use of such a modification in therapy.
priorityDate 2006-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409792867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24751752

Total number of triples: 32.